SARS-CoV Nucleocapsid A2 138-146 (HLA-A*02:01)
( ALNTPKDHI )
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV Nucleocapsid A2 138-146 (HLA-A*02:01) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in MHC ligand assays.
Sequence: | ALNTPKDHI | |
Gene: | N | |
Delivery: | 2-3 days | |
C-Terminus: | OH | |
N-Terminus: | H | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Nucleoprotein | |
Species: | SARS-CoV-2 | |
Allele: | HLA-A*02:01 | |
Application : | Flow Cytometry | |
Indication : | Coronavirus(COVID-19) | |
Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€96.60*
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS